Viral and Cellular N(6)-Methyladenosine (m(6)A) and N(6), 2′-O-Dimethyladenosine (m(6)Am) Epitranscriptomes in KSHV Life Cycle

N (6)-methyladenosine (m(6)A) and N(6), 2′-O-Dimethyladenosine (m(6)Am) modifications (m(6)A/m) of messenger RNA mediate diverse cellular functions. Oncogenic Kaposi’s sarcoma-associated herpesvirus (KSHV) has latent and lytic replication phases that are essential for the development of KSHV-associated cancers. To date, the role of m(6)A/m in KSHV replication and tumorigenesis is unclear. Here, we provide mechanistic insights by examining the viral and cellular m(6)A/m epitranscriptomes during KSHV latent and lytic infection. KSHV transcripts contain abundant m(6)A/m modifications during latent and lytic replication, and these modifications are highly conserved among different cell types and infection systems. Knockdown of YTHDF2 enhanced lytic replication by impeding KSHV RNA degradation. YTHDF2 binds to viral transcripts and differentially mediates their stability. KSHV latent infection induces 5′UTR hypomethylation and 3′UTR hypermethylation of the cellular epitranscriptome, regulating oncogenic and epithelial-mesenchymal transition pathways. KSHV lytic replication induces dynamic reprograming of epitranscriptome, regulating pathways that control lytic replication. These results reveal a critical role of m(6)A/m modifications in KSHV lifecycle and provide rich resources for future investigations.